$144.30
0.490.34%
Last update: Oct 2, 7:45 PM
$144.07
0.260.18%
Merck & Co Inc
MRKNYSE
Merck & Co (MRK) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Merck & Co (MRK) last issued guidance on August 4, 2026 for fiscal year 2026. The company guided earnings per share in the range of $2.66 - $2.76, compared to a consensus EPS estimate of $3.42. Merck & Co also guided revenue in the range of $66.3B - $67.3B for the period.
Compared to prior guidance, Merck & Co lowered its EPS outlook from a previous range of $5.04 - $5.16. On the revenue side, the company maintained its revenue forecast from a prior range of $65.8B - $67B.
Merck & Co has issued 16 guidance updates between October 27, 2022 and August 4, 2026. During this period, the company raised its outlook 3 times and lowered it 6 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.23 | $-1.48 | $2.02 | $2.35 |
| Actual | $-0.13 | $-1.28 | $2.04 | $2.58 |
| Surprise | -156.5% | +13.5% | +0.99% | +9.79% |
| Revenue | ||||
| Estimate | $16.39B | $15.86B | $16.20B | $17.01B |
| Actual | $16.61B | $16.29B | $16.40B | $17.28B |
| Surprise | +1.33% | +2.70% | +1.24% | +1.56% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $2.22 | $1.95 | $2.45 | $2.40 |
| Revenue | ||||
| Consensus | $17.40B | $16.90B | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $-0.13 | $0.23 | -156.5 % |
| Q1 | Apr 30, 2026 | $-1.28 | $-1.48 | 13.5 % |
| Q4 | Feb 3, 2026 | $2.04 | $2.02 | 0.99 % |
| Q3 | Oct 30, 2025 | $2.58 | $2.35 | 9.79 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $16.61B | $16.39B | 1.33 % |
| Q1 | Apr 30, 2026 | $16.29B | $15.86B | 2.70 % |
| Q4 | Feb 3, 2026 | $16.40B | $16.20B | 1.24 % |
| Q3 | Oct 30, 2025 | $17.28B | $17.01B | 1.56 % |
